IPO registrations (S-1, F-1) · Registrants
NANOVIRICIDES, INC.
- SEC CIK
- 1379006 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2008-03-24, last 2020-01-08; 2 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2020-01-24; declared effective 2008-04-11; withdrawal requested 2019-11-06
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1 CONTROLS DRIVE, Shelton, CT 06484
- EIN
- 76-0674577
- Ticker
- NNVC (NYSE)
- EDGAR entity type
- operating
- Insiders and CEO pay
- NANOVIRICIDES, INC. on the corporate pages
Offering terms
- Final price
- $3.00 per share (424B1 filed 2020-01-24)
- Shares sold
- 2,500,000
- Gross proceeds
- $7,500,000 before underwriting discounts and any over-allotment option
- Listing
- NYSE American under the symbol NNVC
- Lead underwriters
- Aegis Capital
- Syndicate
- F- 1 NanoViricides, Inc. Balance Sheets September 30 (2,019); June 30 (2,019)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: NANOVIRICIDES, INC. Fuzzy (name and state)
- Form D issuer: NANOVIRICIDES, INC. EXACT (CIK (EXACT))
- Lobbying client: NANOVIRICIDES INC Fuzzy (name and state)
- SEC filer: NANOVIRICIDES, INC. EXACT (CIK (EXACT))
Filings 19
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2008-03-24 | S-1/A | S-1/A (amendment) | NANOVIRICIDES, INC. | 0001140361-08-007495 ↗ |
| 2008-04-08 | S-1/A | S-1/A (amendment) | NANOVIRICIDES, INC. | 0001140361-08-009093 ↗ |
| 2008-04-11 | EFFECT | EFFECT (declared effective) | NANOVIRICIDES, INC. | 9999999995-08-001066 ↗ |
| 2010-04-29 | EFFECT | EFFECT (declared effective) | NANOVIRICIDES, INC. | 9999999995-10-001230 ↗ |
| 2012-12-21 | EFFECT | EFFECT (declared effective) | NANOVIRICIDES, INC. | 9999999995-12-003616 ↗ |
| 2014-08-01 | EFFECT | EFFECT (declared effective) | NANOVIRICIDES, INC. | 9999999995-14-002371 ↗ |
| 2014-11-17 | EFFECT | EFFECT (declared effective) | NANOVIRICIDES, INC. | 9999999995-14-003378 ↗ |
| 2016-04-14 | EFFECT | EFFECT (declared effective) | NANOVIRICIDES, INC. | 9999999995-16-004208 ↗ |
| 2017-04-25 | EFFECT | EFFECT (declared effective) | NANOVIRICIDES, INC. | 9999999995-17-000938 ↗ |
| 2019-09-27 | S-1 | S-1 (registration) | NANOVIRICIDES, INC. | 0001144204-19-046313 ↗ |
| 2019-11-06 | RW | RW (withdrawal request) | NANOVIRICIDES, INC. | 0001104659-19-060199 ↗ |
| 2019-11-29 | S-1 | S-1 (registration) | NANOVIRICIDES, INC. | 0001104659-19-068364 ↗ |
| 2019-12-17 | S-1/A | S-1/A (amendment) | NANOVIRICIDES, INC. | 0001104659-19-073165 ↗ |
| 2019-12-23 | S-1/A | S-1/A (amendment) | NANOVIRICIDES, INC. | 0001104659-19-075427 ↗ |
| 2020-01-07 | S-1/A | S-1/A (amendment) | NANOVIRICIDES, INC. | 0001104659-20-001737 ↗ |
| 2020-01-08 | S-1/A | S-1/A (amendment) | NANOVIRICIDES, INC. | 0001104659-20-002298 ↗ |
| 2020-01-09 | EFFECT | EFFECT (declared effective) | NANOVIRICIDES, INC. | 9999999995-20-000048 ↗ |
| 2020-01-24 | 424B1 | 424B1 (final prospectus) | NANOVIRICIDES, INC. | 0001104659-20-006423 ↗ |
| 2020-04-02 | EFFECT | EFFECT (declared effective) | NANOVIRICIDES, INC. | 9999999995-20-000674 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-01-08 | S-1/A | registration statement | 2,500,000 | - | NYSE American NNVC | 1 | primary document; shares headline, cover names 1 | document ↗ | ||
| 2020-01-24 | 424B1 | final prospectus | $3.00 | 2,500,000 | $7,500,000 | NYSE American NNVC | 3 | primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Theracour Pharma, Inc. | TenPercentOwner | 46 | 2008–2013 | ||
| Seymour Eugene | Director,Officer; Director,TenPercentOwner; Other | Chief Executive Officer | 4 | 2010–2018 | |
| Diwan Anil | Director,Officer; Director,Officer,TenPercentOwner | President | 52 | 2011–2022 | |
| BONIUK MILTON | Director; Other; TenPercentOwner | 28 | 2013–2025 | ||
| KULKARNI MUKUND S | Director | 1 | 2013 | ||
| VYAS MEETA | Officer | Chief Financial Officer | 3 | 2013–2014 | |
| Day Mark D. | Director | 1 | 2019 | ||
| Jawadakar Makarand | Director | 1 | 2020 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-02-25 | NANOVIRICIDES, INC. | Pharmaceuticals | $6,000,000 | $6,000,000 | 1 | 1 |
| 2019-03-08 | NANOVIRICIDES, INC. | Other Health Care | $2,500,000 | $2,500,000 | 2 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | NANOVIRICIDES, INC. | CT | State business registries | name and state |
| Form D issuer | NANOVIRICIDES, INC. | CT | Form D private offerings | CIK (EXACT) |
| Lobbying client | NANOVIRICIDES INC | CT | Federal lobbying (LDA) | name and state |
| SEC filer | NANOVIRICIDES, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | NanoViricides, Inc. | CT | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CT first:
- CHIREX INC CT
- ACHILLION PHARMACEUTICALS INC CT
- Rib-X Pharmaceuticals, Inc. CT
- Oracle Healthcare Acquisition Corp. CT
- KOLLTAN PHARMACEUTICALS INC CT
- Trevi Therapeutics, Inc. CT
- Yarrow Bioscience, Inc. CT
- Loxo Oncology, Inc. CT
- ARVINAS, INC. CT
- Biohaven Pharmaceutical Holding Co Ltd. CT
In other datasets, the same topic (Health) in CT:
- Nonprofit: AIDS BUDDY NETWORK (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health